The theme of SensUs 2019 is ‘Managing rheumatic disease by measuring with ease’. SensUs 2019 challenges teams to develop biosensors for the detection of adalimumab, an important drug for patients with rheumatoid arthritis. We spoke with Gerda Geven about her experiences as a rheumatoid arthritis patient. 
Read the full article on the SensUs website


Other news